이상반응 보고
| VAERS ID | 2138176 |
|---|---|
| 성별 | 여성 |
| 나이 | |
| 주 코드 | FR |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | ACB5317 |
| 예방접종 횟수 | 3 |
| 접종일 | 2022-01-13 |
| 발병일 | 2022-01-28 |
| 상태 | 입원 사망 |
증상
- 실험실 테스트(Laboratory test)
- 혈관 스텐트 혈전증(Vascular stent thrombosis)
- 폐동맥압(Pulmonary arterial pressure)
이환 중 질병
지병
Medical History/Concurrent Conditions: Antral gastritis; Atrial septal defect (ASD II); Chronic renal failure (Stage III); Diastolic dysfunction; Foramen ovale patent (PFO with spontaneous left-to-right shunt without hemodynamic relevance.); Glaucoma (Angle-closure glaucoma); Infarction (infarction in the middle cerebral artery flow area); Iodine allergy; Lumbar disc herniation; Metabolic syndrome; Obstructive bronchitis; Pulmonary hypertension (Mixed pulmonary hypertension (Pulmonary Artery mean 33mmHg)); Reflux esophagitis; Retinopathy; Sick sinus syndrome; Stroke (Status post slight right-sided stroke as a result of an infarction in the cerebral artery flow area); Thrombophlebitis; Thrombosis (Older lower leg thrombosis on the right); Transient ischemic attack; Varicose vein operation (Status after varicose vein surgery, both in 2008)
기타 의료
이전 예방접종
알레르기
임상 검사
Test Name: lab test; Result Unstructured Data: Test Result:Heparin-induced thrombocytopenia ruled out; Test Name: Pulmonary artery hypertenssin; Result Unstructured Data: Test Result:33 mmHg
증상 상세
After coronary PTCA (percutaneous transluminal coronary angioplasty) stent thrombosis within 30 minutes and again after 1 week with fatal outcome; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from the RA.
Regulatory number: DE-PEI-CADR2022274596.
Other Case identifier(s): DE-CADRPEI-2022274596 (RA Webportal), DE-PEI-202200075899.
A 76 year-old female patient received bnt162b2 (COMIRNATY), administration date 13Jan2022 (Lot number: ACB5317) as dose 3 (booster), 0.
3 ml single for covid-19 immunisation.
Relevant medical history included: "iodine allergy" (unspecified if ongoing); "Metabolic syndrome" (unspecified if ongoing); "ASD" (unspecified if ongoing), notes: ASD II; "PFO" (unspecified if ongoing), notes: PFO with spontaneous left-to-right shunt without hemodynamic relevance.
; "Severe diastolic dysfunction" (unspecified if ongoing); "Sick Sinus Syndrome" (unspecified if ongoing); "Mixed pulmonary hypertension" (unspecified if ongoing), notes: Mixed pulmonary hypertension (Pulmonary Artery mean 33mmHg); "Chronic obstructive bronchitis" (unspecified if ongoing); "Status post slight right-sided stroke" (unspecified if ongoing), notes: Status post slight right-sided stroke as a result of an infarction in the cerebral artery flow area; "infarction in the cerebral artery", start date: 21Jan2016 (unspecified if ongoing), notes: infarction in the middle cerebral artery flow area; "chronic renal failure" (unspecified if ongoing), notes: Stage III; "ischemic attack", start date: Aug2004 (unspecified if ongoing); "Thrombophlebitis", start date: 19Apr2010 (unspecified if ongoing); "Retinopathy" (unspecified if ongoing); "Angle-closure glaucoma" (unspecified if ongoing), notes: Angle-closure glaucoma; "varicose vein surgery", start date: 2008 (unspecified if ongoing), notes: Status after varicose vein surgery, both in 2008; "reflux esophagitis" (unspecified if ongoing); "antral gastritis" (unspecified if ongoing); "Herniated lumbar disc" (unspecified if ongoing); "leg thrombosis" (unspecified if ongoing), notes: Older lower leg thrombosis on the right.
The patient's concomitant medications were not reported.
Past drug history included: Simvastatin, reaction(s): "intolerance".
Vaccination history included: Covid-19 vaccine (1st dose, MANUFACTURE UNKNOWN), for Covid-19 immunisation; Covid-19 vaccine (2nd dose, MANUFACTURE UNKNOWN), for Covid-19 immunisation.
The following information was reported: VASCULAR STENT THROMBOSIS (death, hospitalization) with onset 28Jan2022, outcome "fatal", described as "After coronary PTCA (percutaneous transluminal coronary angioplasty) stent thrombosis within 30 minutes and again after 1 week with fatal outcome".
The patient underwent the following laboratory tests and procedures: laboratory test: heparin-induced thrombocytopenia ruled out; pulmonary arterial pressure: 33 mmHg.
The patient date of death was 06Feb2022.
The reported cause of death was vascular stent thrombosis.
It was not reported if an autopsy was performed.
Relatedness between COMIRNATY and the event (Stent thrombosis) was assessed by the RA as unclassifiable.
No follow-up attempts are possible.
No further information is expected.
; Reported Cause(s) of Death: Stent thrombosis